Start with the core problem and move fast
You’ve got a question that matters and a deadline that doesn’t wait. The central problem: turning messy clinical plans and raw data into clear, defensible statistical conclusions. If you’re scouting a cardiovascular CRO, be explicit about the decision you need the data to support — superiority or non-inferiority, safety margins, or subgroup signals — because every downstream choice hinges on that single sentence.
Define endpoints, estimands, and success criteria up front
Name primary and key secondary endpoints. Map each endpoint to an estimand: population, variable, handling of intercurrent events, and the summary measure. Say whether missing data will be treated with multiple imputation, censoring rules, or sensitivity analyses. Don’t leave “statistical significance” vague; give a precise alpha strategy if you expect multiple looks or multiplicity.
List exact deliverables, formats, and timelines
Ask for an SAP draft before database lock, mock tables generated from a realistic data snapshot, annotated CRFs, dataset specs (SDTM/ADaM), and final programs. Specify formats: R scripts with versioned packages, or validated SAS programs — not both unless you require cross-validation. Tie each deliverable to a date and a review window so the CRO can plan QC runs and code reviews without scrambling.
Lock in data standards and transfer mechanics
Require CDISC compliance if you expect regulatory submission. Specify variable naming, units, and mapping rules for baseline and on-study visits. Define data transfer method (secure SFTP, encrypted API), file formats (XPT, CSV), and a checksum or manifest for each transfer. Ask for a reproducibility package: raw data, harmonized datasets, and the scripts that produced tables and figures.
Prescribe statistical methods and reproducibility checks
Outline model families you’ll accept: mixed models for repeated measures, Cox PH with proportionality checks, logistic regression with predefined covariates. Require diagnostics: residual plots, goodness-of-fit metrics, and sensitivity runs for key assumptions. Request independent code review and unit tests for core functions. Track random seeds and software versions so results can be reproduced exactly.
Clarify roles, governance, and blinding rules
List who does what: the sponsor’s biostatistician approves the SAP; the CRO provides lead statisticians and programmers; a Data Monitoring Committee handles interim reads. State blinding rules for programmers and analysts explicitly. Set cadence for checkpoint meetings and a single source for queries to avoid parallel decision paths.
Common pitfalls—spot them before they cost time
Vague primary endpoints that shift during analysis. Late SAP sign-off that forces analysis reruns. Ignoring multiplicity until after seeing p-values. Poor mapping from CRF to analysis datasets. Not versioning code. Missing provenance for simulated or imputed data. Require fixes: lock the SAP, run mock tables early, automate dataset checks, and demand change logs for every dataset revision.
Real-world anchor and experimental models that inform design
Design choices should reflect observed disease patterns; classic longitudinal data from the Framingham Heart Study anchors incidence and risk-factor progression used in power calculations. When you need preclinical or translational context, pick CRO partners that catalog and validate their in vivo systems — review their portfolio for cardiovascular disease models so your translational assumptions track known physiology and expected signal sizes.
Wrap it into a decisive specification
Specify the question, lock the estimand, demand reproducible code, and schedule tight review loops. That’s the practical map that gets clean analyses on time. If you want the reliability of a partner whose experimental models and programmatic discipline align with those specs, trust the teams at KCI Biotech to match methods to the question rather than retrofit answers after the data lands.